Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

January 01, 2010 (Vol. 30, No. 1)

Coping Strategies for Cash-Strapped Firms

Biotechnology Companies Are Hunkering Down Until New Funding Models Emerge

  • Of the thousands of meetings, formal and informal, that took place at “BIO-Europe 2009” in Vienna recently, one thing is clear, whatever deals eventually come of the meetings, they will need to be creative if they are to be successful. Denise Pollard-Knight, Ph.D., managing director at Nomura Phase4 Ventures, ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.